HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.
Current Therapeutic Drugs Treating COVID-19

SARS (Severe Acute Respiratory Syndrome) is a type of acute respiratory syndrome. Coronavirus-2 (SARS-CoV-2) is the virus that causes COVID-19, which has spread globally. However, there is no precise drug that can prevent or treat COVID-19 at this time. Researchers from all over the world are striving to find the most effective ways to treat and prevent COVID-19, from repurposing existing medications to developing novel antiviral therapies. A list of repurposed drugs with significant pharmacological effects and therapeutic efficacies in treating COVID-19 patients might be developed, according to fresh research and clinical data on the virologic SARS-CoV-2.

  • Antivirals
  • Drug Repurposing
Committee Members
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2024 - A C Matin

A C Matin

Stanford University, United States
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2024 - Tudor Arvinte

Tudor Arvinte

Biopharmaceutics University of Geneva, Switzerland
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2024 - Richard Denk

Richard Denk

SKAN AG, Switzerland
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2024 - Consolato M Sergi

Consolato M Sergi

University of Ottawa, Canada
Pharma 2024 Speakers
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2024 - Ruchika Bajaj

Ruchika Bajaj

University of California, United States
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2024 - Bhupendra Gopalbhai Prajapati

Bhupendra Gopalbhai Prajapati

Shree S.K.Patel College of Pharmaceutical Education and Research, India
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2024 - Dasharath Muljibhai Patel

Dasharath Muljibhai Patel

Graduate School of Pharmacy, India

Submit your abstract Today

Watsapp